Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Oct 15, 2019; 11(10): 842-856
Published online Oct 15, 2019. doi: 10.4251/wjgo.v11.i10.842
Published online Oct 15, 2019. doi: 10.4251/wjgo.v11.i10.842
Figure 5 PBX3 was a direct target of miR-320a.
A: Banding region between miR-320a and PBX3 was predicted by microRNA.org; B: Relative luciferase activities of PBX3 in wild type and mutant; C: PBX3 protein level in gastric cancer (GC) cells after transfection with miR-320a mimics, scramble mimics, miR-320a inhibitor, scramble inhibitor or no transfection for 48 h; D: Protein level of PBX3 in GC tissues and matched adjacent normal tissues. Reference protein was set using GAPDH. C: Cancer tissues; N: Normal tissues; aP < 0.05; bP < 0.01.
- Citation: Li YS, Zou Y, Dai DQ. MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation. World J Gastrointest Oncol 2019; 11(10): 842-856
- URL: https://www.wjgnet.com/1948-5204/full/v11/i10/842.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i10.842